The Patent Lawyer
NewsThe latest IP news – to join our panel of Patent news correspondents, please contact us
Clarivate delivers new AI-powered solutions within Innography for competitive benchmarking and standard-essential patent analysis
AI Classifier delivers patent classification with up to 97% first-pass accuracy for portfolio benchmarking, while SEP Analyzer enhances reporting with clear, intuitive visualizations. Clarivate, a leading global provider of transformative intelligence, today announced...
New Minister appointed with responsibility for intellectual property
The UK Intellectual Property Office (UKIPO) CEO has welcomed the new Minister. Kanishka Narayan MP has been confirmed as the new Minister with responsibility for intellectual property following their appointment as Parliamentary Under-Secretary of State in the...
Pharmacyclics LLC v. Deputy Controller of Patents: the evolving landscape of divisional applications in India
The Calcutta High Court's recent judgment in Pharmacyclics LLC v. Deputy Controller of Patents marks a pivotal moment in Indian Patent Law, offering a clear and definitive interpretation of Section 16 of the Indian Patents Act. For years, a persistent ambiguity...
Bike safety and kitchen elegance win big at the DesignEuropa Awards 2025
COPENHAGEN — Today, the design community recognized two exceptional creations and two notable designers in the sixth edition of the DesignEuropa Awards, organized by the European Union Intellectual Property Office (EUIPO) in the Danish capital. The DesignEuropa Awards...
Beyond stability and mixtures: patent law challenges for biologics in India
A patent application filed for a formulation or composition typically involves at least one active pharmaceutical ingredient (API) that is combined with various excipients. The excipients are substances that serve as carriers, stabilizers, solubilizers, preservatives,...
Samsung’s $112M patent verdict: Maxell makes its mark in IP enforcement
In a significant setback for global tech giant Samsung, a Texas federal jury has handed down a USD 111.7 million verdict in favor of Maxell, ruling that Samsung infringed three patents covering user interface technology, multimedia processing, and smart networking....
Optis v. Apple: what the Federal Circuit’s decision means for functional claiming
The Federal Circuit's June 16, 2025, decision in Optis Cellular Technology, LLC v. Apple Inc., 2025 US App. LEXIS 14745 shines a renewed spotlight on a recurring challenge in patent law: functional claiming. Specifically, it reaffirms the court's willingness to apply...
Delhi High Court denies AbbVie’s anti-cMet ADC patent
This article discusses an appeal filed by AbbVie Biotherapeutics Inc. and AbbVie Inc. (Appellants) at the Delhi High Court against the refusal of their patent application (Application No. 201817047767) for an anti-cMet antibody-drug conjugate by the Assistant...
UPC and EPO diverge on inventive step: lessons from Amgen’s PCSK9 patent battle
In a landmark test of the new Unified Patent Court (UPC), the European patent landscape faces a striking divergence between the UPC and the European Patent Office (EPO) on the issue of inventive step. The dispute centers on Amgen's European patent EP 3 666 797, which...
Therapeutic efficacy is a must for a novel intermediate compound to overcome Section 3(d) objection
In an appeal case between Zeria Pharmaceutical Co. Ltd., v. The Controller of Patents (C.A.(COMM.IPD-PAT) 452/2022) before the Delhi High Court, wherein the appellant - a Japanese Corporation - filed an Indian Patent Application, numbered 3630/DLNP/2011 (the subject...
Should translation requirements apply equally in patent law?
A recent High Court judgment in India highlights a potential procedural fairness question in patent examination regarding English translation standards. While patent applicants face rigorous translation requirements under multiple Patent Rules, with severe...
UPC validates second medical use patent in Sanofi v. Amgen antibody therapeutics ruling, finds non-infringement
The Düsseldorf Local Division of the Unified Patent Court (UPC) has handed down a key decision in UPC CFI 505/2024, affirming the validity of a second medical use patent owned by Regeneron and licensed to Sanofi. The case involved alleged infringement by Amgen’s PCSK9...
Annual Report 2024 of the Boards of Appeal of the European Patent Office
The Annual Report 2024 of the Boards of Appeal of the European Patent Office has been published today. It is available in English, German, and French on the Boards' website. Delivering decisions of the highest quality continued to be a central priority in 2024. As in...
Certainty for businesses and choice for consumers as UK maintains IP rights regime
No legislative changes mean businesses can continue operating under the existing exhaustion of intellectual property rights regime without any new requirements. The UK+ regime protects creators and innovators while ensuring fair competition in the marketplace and...
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.